Приказ основних података о документу

dc.creatorŠaponjić, Jasna
dc.creatorMejías, Rebeca
dc.creatorNikolovski, Neda
dc.creatorDragic, Milorad
dc.creatorCanak, Asuman
dc.creatorPapoutsopoulou, Stamatia
dc.creatorGürsoy-Özdemir, Yasemin
dc.creatorFladmark, Kari
dc.creatorNtavaroukas, Panagiotis
dc.creatorBayar Muluk, Nuray
dc.creatorZeljkovic Jovanovic, Milica
dc.creatorFontán-Lozano, Ángela
dc.creatorComi, Cristoforo
dc.creatorMarino, Franca
dc.date.accessioned2024-04-16T13:27:09Z
dc.date.available2024-04-16T13:27:09Z
dc.date.issued2024
dc.identifier.issn1422-0067
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/6685
dc.description.abstractParkinson’s disease (PD) is a chronic, age-related, progressive multisystem disease associated with neuroinflammation and immune dysfunction. This review discusses the methodological approaches used to study the changes in central and peripheral immunity in PD, the advantages and limitations of the techniques, and their applicability to humans. Although a single animal model cannot replicate all pathological features of the human disease, neuroinflammation is present in most animal models of PD and plays a critical role in understanding the involvement of the immune system (IS) in the pathogenesis of PD. The IS and its interactions with different cell types in the central nervous system (CNS) play an important role in the pathogenesis of PD. Even though culture models do not fully reflect the complexity of disease progression, they are limited in their ability to mimic long-term effects and need validation through in vivo studies. They are an indispensable tool for understanding the interplay between the IS and the pathogenesis of this disease. Understanding the immune-mediated mechanisms may lead to potential therapeutic targets for the treatment of PD. We believe that the development of methodological guidelines for experiments with animal models and PD patients is crucial to ensure the validity and consistency of the results.sr
dc.language.isoensr
dc.publisherBasel: MDPIsr
dc.relationCOST Action IMMUPARKNET (CA 21117)sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceInternational Journal of Molecular Sciencessr
dc.subjectParkinson’s diseasesr
dc.subjectimmune systemssr
dc.subjectneuroinflammationsr
dc.subjectneurodegenerationsr
dc.subjectperipheral immune cellssr
dc.subjectanimal modelssr
dc.subjectcellular modelssr
dc.titleExperimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Diseasesr
dc.typereviewsr
dc.rights.licenseBYsr
dc.rights.holder© 2024 by the authors. Licensee MDPI, Basel, Switzerlandsr
dc.citation.issue8
dc.citation.volume25
dc.identifier.doi10.3390/ijms25084330
dc.identifier.scopus2-s2.0-85191376334
dc.citation.spage4330
dc.type.versionpublishedVersionsr
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/17621/bitstream_17621.pdf


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу